Stock PMGMU PRIVETERRA ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Priveterra Acquisition Corp. Nasdaq

Equities

PMGMU

US74275N2018

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
AEON Biopharma Completes Business Combination With Priveterra Acquisition; Shares Slump
MT
Priveterra Acquisition Completes Merger With AEON Biopharma
MT
Priveterra Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
AEON Biopharma, Inc. completed the acquisition of Priveterra Acquisition Corp. from Priveterra Sponsor, LLC, Empyrean Capital Overseas Master Fund, Ltd., managed by Empyrean Capital Partners, LP, Medy-Tox Inc., Daewoong pharmaceutical Co.,Ltd, Strathspey Crown LLC and others in a reverse merger transaction.
CI
Priveterra Acquisition Gets New York Stock Exchange Approval for Listing of AEON Biopharma Stock, Warrants
MT
Priveterra Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
AEON Biopharma, Inc. entered into a definitive business combination agreement to acquire Priveterra Acquisition Corp. from Priveterra Sponsor, LLC, Empyrean Capital Overseas Master Fund, Ltd., managed by Empyrean Capital Partners, LP, Medy-Tox Inc., Daewoong pharmaceutical Co.,Ltd, Strathspey Crown LLC and others in a reverse merger transaction.
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Priveterra Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Priveterra Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
PRIVETERRA ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
PRIVETERRA ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Priveterra Acquisition Corp. has completed an IPO in the amount of $240 million.
CI
Priveterra Acquisition Corp. has filed an IPO in the amount of $200 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PMGM Stock
  4. PMGMU Stock
  5. News Priveterra Acquisition Corp.
  6. Highlights